Ki67 targeted strategies for cancer therapy.

about

Ki67 targeted strategies for cancer therapy.

Item

http://www.wikidata.org/entity/Q45873470

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ki67 targeted strategies for cancer therapy.

@en

Ki67 targeted strategies for cancer therapy.

@nl

type

Item

label

Ki67 targeted strategies for cancer therapy.

@en

Ki67 targeted strategies for cancer therapy.

@nl

prefLabel

Ki67 targeted strategies for cancer therapy.

@en

Ki67 targeted strategies for cancer therapy.

@nl

P1476

Ki67 targeted strategies for cancer therapy

@en

P2093

C Yang

http://www.w3.org/2001/XMLSchema#string

J Zhang

http://www.w3.org/2001/XMLSchema#string

J Zheng

http://www.w3.org/2001/XMLSchema#string

K Xu

http://www.w3.org/2001/XMLSchema#string

M Ding

http://www.w3.org/2001/XMLSchema#string

P2860

shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy

The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins

The Ki-67 protein: from the known and the unknown

A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients.

Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer

Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion.

A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors

A status report on RNAi therapeutics.

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.

Targeting nuclear RNA for in vivo correction of myotonic dystrophy

P2888

s12094-017-1774-3

P304

570-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-017-1774-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Liantao Li

L Mao

P577

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092328326

http://www.w3.org/2001/XMLSchema#string

P698

29058263

http://www.w3.org/2001/XMLSchema#string